Free Trial

$33.25B Priced Tuesday, AbbVie lead........>

PIPELINE
PIPELINE: $33.25B Priced Tuesday, AbbVie lead w/largest issue of year
Date $MM Issuer/Rating/Desc/Maturity/Yld; Priced *; Launch #:
11/13 $1B Kommunivest WNG +3Y +12 
11/13 $Benchmark Egypt 4Y, +12Y, 40Y
11/?? Nationwide Fncl Servc investor call
11/?? Chatter: Sprint
11/?? Chatter: T-Mobile US
-
$30B AbbVie jumbo 10-part priced late Tuesday, 4th largest on record.
11/12 $30B *AbbVie 10-tranche: $750M 1.5Y FRN 3ML +35, $1.75B 2Y +50, $750M 2Y
FRN L+46, $3B 3Y +65, $750M 3Y FRN L+65, $3.75B 5Y +90, $4B 7Y +115, $5.5B 10Y
+130, $4B 20Y +170, $5.75B 30Y +190. 
11/12 $2B *BNP Paribas 6NC5 +110
11/12 $1.25B *Westpac 5.25Y +63

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.